News ArticlesBreast cancer awareness monthBreast cancer is the most common cancer among women worldwide with more than 2 million new cases diagnosed each year. The cancer develops in the mammary gland with the most common forms being adenocarcinomas arising from the epithelial cells that line the milk ducts or the milk-producing lobules. Among these invasive ductal carcinoma (IDC) is the most common type and accounts for around 80% of the cases...Read more The complexity of multi-localizing and multi-functional proteinsChanges in metabolic pathways are frequently seen in cancer cells, and mutations in certain metabolic genes may even play a direct role in cancer development and progression. One gene for which this is true is the multi-localizing gene fumarate hydratase...Read more Multiplex tissue image of the month - FATE1 in testisCancer-associated protein fetal and adult testis expressed 1 (gene: FATE1) is mapped to reproductive supporting cells in normal testis tissue using multiplex immunohistochemistry (mIHC/IF)...Read more Multiplex tissue image of the month - PDX1 in pancreasThis month, the expression of beta-cell-associated transcription factor PDX1 within the endocrine pancreas is displayed through multiplex immunohistochemistry (mIHC/IF)...Read more Reducing uncertainty in drug development: a Q&A with Thomas HelledayT cells are central drivers of inflammation across autoimmune and inflammatory diseases, yet current therapies inadequately target pathogenic T-cell pathways, limiting durable disease control. In a recent study published in Signal Transduction and Targeted Therapy, a team led by Thomas Helleday and Theodora Manolakou, identified a novel, targetable transcriptional-metabolic axis that sustains inflammatory T-cell responses. In an interview by Gustav Ceder, Helleday discusses the novel findings and ongoing lines of research...Read more |